SCHEMBL18169342

SCHEMBL18169342

CCOC(=O)C1OC(C)(C)Oc2ccc(OC)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ HTR1A P08908 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40
▸ TSHR P16473 3/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAPT P10636 5/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ HPGD P15428 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16809585 0.85 ALPG (0.46) ALDH1A1SIGMAR1TSHRMEN1KMT2A
SCHEMBL16809589 0.85 KCNE1 (0.42) ALDH1A1TDP1SIGMAR1TSHRMEN1
SCHEMBL16809481 0.78 ALPG (0.43) ALDH1A1SIGMAR1MEN1KMT2AMAPT
SCHEMBL19905593 0.77 HTR2B (0.39) ALDH1A1HTR1AHTR2BSIGMAR1TSHR
SCHEMBL16809431 0.75 HTR2B (0.41) ALDH1A1TDP1HTR1AHTR2BSIGMAR1
SCHEMBL16797756 0.74 HTR2B (0.42) ALDH1A1TDP1HTR1AHTR2BSIGMAR1
SCHEMBL16797753 0.73 HTR2B (0.41) ALDH1A1TDP1HTR1AHTR2BSIGMAR1
SCHEMBL18169360 0.72 SIGMAR1 (0.43) ALDH1A1TDP1SIGMAR1TSHRMEN1
SCHEMBL12967407 0.72 ALDH1A1 (0.47) ALDH1A1TDP1HTR1AHTR2BSIGMAR1
SCHEMBL16809708 0.72 ALPG (0.45) ALDH1A1SIGMAR1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10081615-B2 Sulfamate derivative compounds for use in treating or alleviating pain BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-09-25 — — US disclosed
EP-3079687-B1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN BIO-PHARM SOLUTIONS CO LTD (KR) 2018-02-28 — — EP disclosed
EP-3079687-B1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN BIO-PHARM SOLUTIONS CO LTD (KR) 2018-02-28 — — EP disclosed
US-20160311792-A1 Sulfamate Derivative Compounds for Use in Treating or Alleviating Pain BIO-PHARM SOLUTIONS CO., LTD. (KR) 2016-10-27 — — US disclosed
US-20160311792-A1 Sulfamate Derivative Compounds for Use in Treating or Alleviating Pain BIO-PHARM SOLUTIONS CO., LTD. (KR) 2016-10-27 — — US disclosed
US-20160311792-A1 Sulfamate Derivative Compounds for Use in Treating or Alleviating Pain BIO-PHARM SOLUTIONS CO., LTD. (KR) 2016-10-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311792-A1 Sulfamate Derivative Compounds for Use in Treating or Alleviating Pain SULT2A1, SULT1A1, TRPV1 ALDH1A1 894/4885TDP1 3459/4885HTR1A 761/4885
US-10081615-B2 Sulfamate derivative compounds for use in treating or alleviating pain SULT2A1, SULT1A1, TRPV1 ALDH1A1 894/4885TDP1 3459/4885HTR1A 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback